secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARVINAS, INC. (ARVN)
CIK:        0001655759
Form:       8-K
Filed at:   2024-06-24T23:59:59+00:00
Accession:  0001655759-24-000101
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Arvinas appoints Andrew Saik as CFO, effective June 24, 2024
------------------------------------------------------------

- Andrew Saik, former Intercept Pharmaceuticals CFO, named permanent CFO at Arvinas.
- Base salary of $525,000; annual bonus target of 45% of base salary.
- Granted 94,418 options and 61,409 RSUs, both vesting over four years.
- Randy Teel, Ph.D., who served as interim CFO, returns to chief business officer role.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1655759/000165575924000101/0001655759-24-000101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1655759/000165575924000101/arvn-20240622.htm
  HTML page:      https://secwatch.observer/filing/0001655759-24-000101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer